AstraZeneca Pharma hits 52-week low on promoter stake sale plan
AstraZeneca Pharmaceuticals AB Sweden has decided to reduce its shareholding in the company to meet minimum public shareholding norm.

Explore Business Standard
AstraZeneca Pharmaceuticals AB Sweden has decided to reduce its shareholding in the company to meet minimum public shareholding norm.

First Published: Mar 06 2013 | 9:24 AM IST